Trial Profile
A Double Blinded Randomized Placebo Controlled Study: To Investigate the Role of Upstream High Dose Statin Treatment in Patients With ST Segment Elevation Myocardial Infarction.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions
- Acronyms IMPRES
- 29 Nov 2016 Status changed from recruiting to completed.
- 31 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.
- 02 Aug 2011 Planned End Date changed from 1 Oct 2010 to 1 Oct 2012 as reported by ClinicalTrials.gov.